Whomever controls the data will be in control, and we want to position ACR members to be in control throughout expected changes in the healthcare system. As we strive to optimally advance rheumatology over the next several decades, both in clinical and research settings, it is imperative that the ACR have the appropriate data to help position rheumatologists to better control their futures. We believe that the expansion of the ACR’s registry efforts with RISE will be an important step toward informing and empowering ACR members.
Dr. O’Dell is director of the Internal Medicine Residency Program and division chief of rheumatology at the University of Nebraska, Omaha and the Omaha VA medical centers. Contact him via e-mail at [email protected].